1. Home
  2. STN vs QGEN Comparison

STN vs QGEN Comparison

Compare STN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stantec Inc

STN

Stantec Inc

N/A

Current Price

$72.21

Market Cap

7.5B

ML Signal

N/A

QGEN

Qiagen N.V.

N/A

Current Price

$50.19

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STN
QGEN
Founded
1954
1986
Country
Canada
Netherlands
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
9.0B
IPO Year
2005
1998

Fundamental Metrics

Financial Performance
Metric
STN
QGEN
Price
$72.21
$50.19
Analyst Decision
Hold
Analyst Count
0
12
Target Price
N/A
★ $49.02
AVG Volume (30 Days)
270.0K
★ 4.8M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
0.95%
★ 5.48%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.97
$2.18
Revenue Next Year
$5.63
$5.03
P/E Ratio
$28.96
★ $24.01
Revenue Growth
N/A
N/A
52 Week Low
$65.35
$32.53
52 Week High
$111.02
$57.82

Technical Indicators

Market Signals
Indicator
STN
QGEN
Relative Strength Index (RSI) 60.72 71.26
Support Level $71.90 $49.37
Resistance Level $73.03 $50.34
Average True Range (ATR) 1.57 1.01
MACD 0.49 0.21
Stochastic Oscillator 87.77 88.55

Price Performance

Historical Comparison
STN
QGEN

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Share on Social Networks: